sentavio-shutterstock-com-1

Sentavio / Shutterstock.com

15 June 2016Big Pharma

Optimising IP strategies: Life Sciences Law Forum preview

The fourth annual Life Sciences Law Forum, hosted by Thomson Reuters, aims to focus on equipping lawyers with practical solutions and strategies for addressing the challenges their organisation may face throughout a product’s lifecycle.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gene tech firm fends off injunction in test kit dispute

Comparing life sciences IP in Brazil and the US

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

GSK triumphs in EPO appeal, revoking Pfizer patent